
June 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma

June 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology

June 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, martin lamb

June 26, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britz, retrogenix

June 25, 2014 Research and Development, Sales and Marketing BIA, BIO, Steve Bates, UK, Willetts, life sciences, san diego

June 25, 2014 Research and Development, Sales and Marketing ASCO, BMS, Cancer, Yervoy, braf, melanoma, nivolumab

June 25, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bamboo, jones, lake, medical communications, pegg

June 24, 2014 Research and Development, Sales and Marketing Esbriet, InterMune, Lemtrada, Orphan, dificlir, innovative, pif, prix galion, selincro

June 24, 2014 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, FDA, olaparib, ovarian

June 24, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, dimension, haemophilia, haemophilia a, therapeutics

June 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, cello health insight, itani

June 23, 2014 Research and Development, Sales and Marketing MS, Roche, inception sciences, multiple sclerosis, versant ventures

June 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Hub Wales, Wales, ian barwick
June 23, 2014 Research and Development, Sales and Marketing BIA, Steve Bates, biomedical catalyst, funding

June 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research